These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 31275164)
1. Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models. Lu D; Xia Y; Chen Z; Chen A; Wu Y; Jia J; Sun A; Zou Y; Qian J; Ge J Front Physiol; 2019; 10():750. PubMed ID: 31275164 [TBL] [Abstract][Full Text] [Related]
2. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue. Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364 [TBL] [Abstract][Full Text] [Related]
3. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy. Liu M; Zhai L; Yang Z; Li S; Liu T; Chen A; Wang L; Li Y; Li R; Li C; Tan M; Chen Z; Qian J Mol Cell Proteomics; 2023 Dec; 22(12):100667. PubMed ID: 37852321 [TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824 [TBL] [Abstract][Full Text] [Related]
5. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807 [TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies. Qiao A; Zhao Z; Zhang H; Sun Z; Cui X Pathol Res Pract; 2017 May; 213(5):548-557. PubMed ID: 28318762 [TBL] [Abstract][Full Text] [Related]
7. Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics. Huang G; Huang Z; Peng Y; Wang Y; Liu W; Xue Y; Yang W Pharmgenomics Pers Med; 2021; 14():1169-1184. PubMed ID: 34557019 [TBL] [Abstract][Full Text] [Related]
8. Asporin is a Potential Promising Biomarker for Common Heart Failure. Zhang K; Wu M; Qin X; Wen P; Wu Y; Zhuang J DNA Cell Biol; 2021 Feb; 40(2):303-315. PubMed ID: 33605799 [TBL] [Abstract][Full Text] [Related]
9. m6A RNA methylation modification is involved in the disease course of heart failure. Yu L; Cai S; Guo X Biotechnol Genet Eng Rev; 2024 Oct; 40(2):961-975. PubMed ID: 36943073 [TBL] [Abstract][Full Text] [Related]
10. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513 [TBL] [Abstract][Full Text] [Related]
11. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. Brodde OE; Vogelsang M; Broede A; Michel-Reher M; Beisenbusch-Schäfer E; Hakim K; Zerkowski HR J Cardiovasc Pharmacol; 1998 Apr; 31(4):585-94. PubMed ID: 9554809 [TBL] [Abstract][Full Text] [Related]
12. Altered protein levels in the isolated extracellular matrix of failing human hearts with dilated cardiomyopathy. DeAguero JL; McKown EN; Zhang L; Keirsey J; Fischer EG; Samedi VG; Canan BD; Kilic A; Janssen PM; Delfín DA Cardiovasc Pathol; 2017; 26():12-20. PubMed ID: 27837684 [TBL] [Abstract][Full Text] [Related]
13. Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. Thorin E J Cardiovasc Pharmacol; 2001 Jul; 38(1):90-8. PubMed ID: 11444506 [TBL] [Abstract][Full Text] [Related]
14. Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy. Colak D; Alaiya AA; Kaya N; Muiya NP; AlHarazi O; Shinwari Z; Andres E; Dzimiri N PLoS One; 2016; 11(10):e0162669. PubMed ID: 27711126 [TBL] [Abstract][Full Text] [Related]
15. Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy. Lin F; Gong X; Yu P; Yue A; Meng Q; Zheng L; Chen T; Han L; Cao H; Cao J; Liang X; Hu H; Li Y; Liu Z; Zhou X; Fan H Front Genet; 2019; 10():1116. PubMed ID: 31781171 [TBL] [Abstract][Full Text] [Related]
16. Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy. Huang Y; Xuan L; Xu Q; Wang J; Liu J J Thorac Dis; 2024 Jul; 16(7):4655-4665. PubMed ID: 39144301 [TBL] [Abstract][Full Text] [Related]
17. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy. Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540 [TBL] [Abstract][Full Text] [Related]
18. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy]. Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099 [TBL] [Abstract][Full Text] [Related]
19. The role of the nuclear lamins in the pathogenesis of heart failure in patients undergoing cardiac transplantation. Cortés R; Roselló-Lletí E; Rivera M; Martínez-Dolz L; Azorín I; Salvador A; Portolés M Transplant Proc; 2009; 41(6):2227-30. PubMed ID: 19715882 [TBL] [Abstract][Full Text] [Related]
20. Divergent mitochondrial biogenesis responses in human cardiomyopathy. Ahuja P; Wanagat J; Wang Z; Wang Y; Liem DA; Ping P; Antoshechkin IA; Margulies KB; Maclellan WR Circulation; 2013 May; 127(19):1957-67. PubMed ID: 23589024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]